{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:38:22Z","timestamp":1781786302408,"version":"3.54.5"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T00:00:00Z","timestamp":1468022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10549-016-3901-1","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T02:18:01Z","timestamp":1468030681000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women"],"prefix":"10.1007","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-166X","authenticated-orcid":false,"given":"Giorgio","family":"Secreto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Sieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Agnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Grioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Muti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnett","family":"Zumoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Sant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Meneghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,9]]},"reference":[{"key":"3901_CR1","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","volume":"381","author":"J Cuzick","year":"2013","unstructured":"Cuzick J, Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix AZ, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL (2013) SERM chemoprevention of breast cancer overview group. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet 381:1827\u20131834","journal-title":"Lancet"},{"key":"3901_CR2","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","volume":"364","author":"PE Goss","year":"2011","unstructured":"Goss PE, Ingle JN, Al\u00e9s-Mart\u00ednez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H (2011) NCIC CTG MAP.3 study investigators: exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364:2381\u20132391","journal-title":"N Engl J Med"},{"key":"3901_CR3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","volume":"383","author":"J Cuzick","year":"2014","unstructured":"Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A, on behalf of the IBIS-II investigators (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomized placebo-controlled trial. Lancet 383:1041\u20131048","journal-title":"Lancet"},{"key":"3901_CR4","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","volume":"31","author":"K Visvanathan","year":"2013","unstructured":"Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG 3rd, Wade JL, Lippman SM (2013) Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31:2942\u20132962","journal-title":"J Clin Oncol"},{"key":"3901_CR5","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","volume":"28","author":"ME Ropka","year":"2010","unstructured":"Ropka ME, Keim J, Philbrick JT (2010) Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol 28:3090\u20133095","journal-title":"J Clin Oncol"},{"key":"3901_CR6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1055-9965.EPI-09-0930","volume":"19","author":"EA Waters","year":"2010","unstructured":"Waters EA, Cronin KA, Graubard BI, Han PK, Freedman AN (2010) Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Cancer Epidemiol Biomark Prev 19:443\u2013446","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3901_CR7","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879\u20131886","journal-title":"J Natl Cancer Inst"},{"key":"3901_CR8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","volume":"93","author":"B Rockhill","year":"2001","unstructured":"Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA et al (2001) Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358\u2013366","journal-title":"J Natl Cancer Inst"},{"key":"3901_CR9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111\u20131130","journal-title":"Stat Med"},{"key":"3901_CR10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-011-1818-2","volume":"132","author":"C Meads","year":"2012","unstructured":"Meads C, Ahmed I, Riley RD (2012) A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat 132:365\u2013377","journal-title":"Breast Cancer Res Treat"},{"key":"3901_CR11","unstructured":"Secreto G (2012) The androgen-excess theory of breast cancer. In: Secreto G, Zumoff B (eds) The androgen-excess theory of breast cancer, Research Signpost, Trivandrum, pp 47\u201370. http:\/\/www.trnres.com\/ebook.php"},{"key":"3901_CR12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.285.7.885","volume":"285","author":"R Yancik","year":"2001","unstructured":"Yancik R, Wesley MN, Lynn AG, Ries LAG, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55\u00a0years and older. JAMA 285:885\u2013892","journal-title":"JAMA"},{"key":"3901_CR13","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1158\/1055-9965.EPI-06-0191","volume":"15","author":"WF Anderson","year":"2006","unstructured":"Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomark Prev 15:1899\u20131905","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3901_CR14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMra000471","volume":"346","author":"CJ Gruber","year":"2002","unstructured":"Gruber CJ, Tschugguel W, Schneeberger C, Huber JC (2002) Production and actions of estrogens. N Engl J Med 346:340\u2013352","journal-title":"N Engl J Med"},{"key":"3901_CR15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606\u2013616","journal-title":"J Natl Cancer Inst"},{"key":"3901_CR16","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jnci\/djh336","volume":"96","author":"SA Missmer","year":"2004","unstructured":"Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856\u20131865","journal-title":"J Natl Cancer Inst"},{"key":"3901_CR17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1158\/1055-9965.EPI-04-0375","volume":"14","author":"SR Cummings","year":"2005","unstructured":"Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA (2005) Sex hormones, risk factors, and risk of estrogen receptor\u2013positive breast cancer in older women: a long-term prospective study. Cancer Epidemiol Biomark Prev 14:1047\u20131051","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3901_CR18","unstructured":"Secreto G (2012) Endocrine classification of postmenopausal breast cancers. In: Secreto G, Zumoff B (eds) The androgen-excess theory of breast cancer, Research Signpost, Trivandrum, pp 79\u2013109. http:\/\/www.trnres.com\/ebook.php"},{"key":"3901_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/1471-2407-12-599","volume":"12","author":"G Secreto","year":"2012","unstructured":"Secreto G, Venturelli E, Meneghini E, Carcangiu ML, Paolini B, Agresti R, Pellitteri C, Berrino F, Gion M, Cogliati P, Sarag\u00f2 G, Micheli A (2012) Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers. BMC Cancer 12:599","journal-title":"BMC Cancer"},{"key":"3901_CR20","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1055-9965.EPI-09-0540","volume":"18","author":"G Secreto","year":"2009","unstructured":"Secreto G, Venturelli E, Meneghini E, Greco M, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A, Micheli A (2009) Testosterone and biological characteristics of breast cancers in postmenopausal women. Cancer Epidemiol Biomark Prev 18:2942\u20132948","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3901_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5301\/JBM.2011.8883","volume":"26","author":"G Secreto","year":"2011","unstructured":"Secreto G, Meneghini E, Venturelli E, Cogliati P, Agresti R, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A, Micheli A (2011) Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study. Int J Biol Markers 26:241\u2013246","journal-title":"Int J Biol Markers"},{"issue":"Suppl 4","key":"3901_CR22","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","volume":"77","author":"HG Burger","year":"2002","unstructured":"Burger HG (2002) Androgen production in women. Fertil Steril 77(Suppl 4):S3\u2013S5","journal-title":"Fertil Steril"},{"key":"3901_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.steroids.2011.10.002","volume":"77","author":"J Kotsopoulos","year":"2012","unstructured":"Kotsopoulos J, Narod SA (2012) Androgens and breast cancer. Steroids 77:1\u20139","journal-title":"Steroids"},{"key":"3901_CR24","first-page":"1429","volume":"80","author":"B Zumoff","year":"1995","unstructured":"Zumoff B, Strain GW, Miller LK, Rosner W (1995) Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 80:1429\u20131430","journal-title":"J Clin Endocrinol Metab"},{"key":"3901_CR25","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","volume":"90","author":"SL Davison","year":"2005","unstructured":"Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847\u20133853","journal-title":"J Clin Endocrinol Metab"},{"key":"3901_CR26","first-page":"2832","volume":"85","author":"HG Burger","year":"2000","unstructured":"Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL (2000) A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85:2832\u20132838","journal-title":"J Clin Endocrinol Metab"},{"key":"3901_CR27","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1210\/jc.2007-0581","volume":"92","author":"RH Fogle","year":"2007","unstructured":"Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ (2007) Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 92:3040\u20133043","journal-title":"J Clin Endocrinol Metab"},{"key":"3901_CR28","first-page":"645","volume":"85","author":"GA Laughlin","year":"2000","unstructured":"Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von M\u00fchlen D (2000) Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo study. J Clin Endocrinol Metab 85:645\u2013651","journal-title":"J Clin Endocrinol Metab"},{"key":"3901_CR29","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/humrep\/dep209","volume":"24","author":"MFR Sowers","year":"2009","unstructured":"Sowers MFR, Zheng H, McConnell D, Nan B, Karvonen-Gutierrez CA, Randolph JF Jr (2009) Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging. Hum Reprod 24:2276\u20132285","journal-title":"Hum Reprod"},{"key":"3901_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0015-0282(16)56810-1","volume":"62","author":"EY Adashi","year":"1994","unstructured":"Adashi EY (1994) The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril 62:20\u201327","journal-title":"Fertil Steril"},{"key":"3901_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5122(02)00140-8","volume":"43","author":"VH Jongen","year":"2002","unstructured":"Jongen VH, Sluijmer AV, Heineman MJ (2002) The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer. Maturitas 43:77\u201385","journal-title":"Maturitas"},{"key":"3901_CR32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1210\/jcem-26-6-593","volume":"26","author":"BF Rice","year":"1966","unstructured":"Rice BF, Savard K (1966) Steroid hormone formation in the human ovary. IV. Ovarian stromal compartment; formation of radioactive steroids from acetate-1\u201314C and action of gonadotropins. J Clin Endocrinol Metab 26:593\u2013609","journal-title":"J Clin Endocrinol Metab"},{"key":"3901_CR33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-642-74011-4_2","volume-title":"Ovarian pathology, current topics in pathology","author":"HE Stegner","year":"1989","unstructured":"Stegner HE (1989) Hormonally related non-neoplastic condition of the ovary. In: Nogales Francisco (ed) Ovarian pathology, current topics in pathology. Springer, Berlin, pp 11\u201339"},{"key":"3901_CR34","first-page":"160","volume":"53","author":"SC Sommers","year":"1952","unstructured":"Sommers SC (1952) Ovarian stromal hyperplasia in breast cancer. AMA Arch Pathol 53:160\u2013166","journal-title":"AMA Arch Pathol"},{"key":"3901_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0378-5122(86)90008-3","volume":"8","author":"A Lucisano","year":"1986","unstructured":"Lucisano A, Russo N, Acampora MG, Fabiano A, Fattibene M, Parlati E, Maniccia E, Dell\u2019Acqua S (1986) Ovarian and peripheral androgen and oestrogen levels in post-menopausal women: correlations with ovarian histology. Maturitas 8:57\u201365","journal-title":"Maturitas"},{"key":"3901_CR36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00042192-199805040-00004","volume":"5","author":"AV Sluijmer","year":"1998","unstructured":"Sluijmer AV, Heineman MJ, Koudstaal J, Theunissen PH, de Jong FH, Evers JL (1998) Relationship between ovarian production of estrone, estradiol, testosterone, and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women. Menopause 5:207\u2013210","journal-title":"Menopause"},{"key":"3901_CR37","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1471-0528.2003.02389.x","volume":"110","author":"VHWM Jongen","year":"2003","unstructured":"Jongen VHWM, Holleman H, van der Zee AGJ, Santema JG, Heineman MJ (2003) Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer. Br J Obstet Gynaecol 110:690\u2013695","journal-title":"Br J Obstet Gynaecol"},{"key":"3901_CR38","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/1055-9965.EPI-12-0201","volume":"21","author":"J Kotsopoulos","year":"2012","unstructured":"Kotsopoulos J, Lubinski J, Lynch HT, Kim-Sing C, Neuhausen S, Demsky R, Foulkes WD, Ghadirian P, Tung N, Ainsworth P, Senter L, Karlan B, Eisen A, Eng C, Weitzel J, Gilchrist DM, Blum JL, Zakalik D, Singer C, Fallen T, Ginsburg O, Huzarski T, Sun P, Narod SA (2012) Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 21:1089\u20131096","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3901_CR39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12672-014-0209-7","volume":"6","author":"J Kotsopoulos","year":"2015","unstructured":"Kotsopoulos J, Shafrir AL, Rice M, Hankinson SE, Eliassen AH, Tworoger SS, Narod SA (2015) The relationship between bilateral oophorectomy and plasma hormone levels in postmenopausal women. Horm Cancer 6:54\u201363","journal-title":"Horm Cancer"},{"key":"3901_CR40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/bcr2942","volume":"13","author":"NF Boyd","year":"2011","unstructured":"Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2011) Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 13:223","journal-title":"Breast Cancer Res"},{"key":"3901_CR41","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/jnci\/djm062","volume":"99","author":"RM Tamimi","year":"2007","unstructured":"Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178\u20131187","journal-title":"J Natl Cancer Inst"},{"key":"3901_CR42","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/bjc.2014.64","volume":"110","author":"MJ Schoemaker","year":"2014","unstructured":"Schoemaker MJ, Folkerd EJ, Jones ME, Rae M, Allen S, Ashworth A, Dowsett M, Swerdlow AJ (2014) Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study. Br J Cancer 110:1898\u20131907","journal-title":"Br J Cancer"},{"key":"3901_CR43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/jnci\/djr079","volume":"103","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103:744\u2013752","journal-title":"J Natl Cancer Inst"},{"key":"3901_CR44","first-page":"3223","volume":"32","author":"G Secreto","year":"2012","unstructured":"Secreto G, Zumoff B (2012) Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer. Anticancer Res 32:3223\u20133228","journal-title":"Anticancer Res"},{"key":"3901_CR45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10549-012-2391-z","volume":"137","author":"X Zhang","year":"2013","unstructured":"Zhang X, Tworoger SS, Eliassen AH, Hankinson SE (2013) Postmenopausal plasma sex hormone levels and breast cancer risk over 20\u00a0years of follow-up. Breast Cancer Res Treat 137:883\u2013892","journal-title":"Breast Cancer Res Treat"},{"key":"3901_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.steroids.2014.09.001","volume":"99","author":"Endogenous Hormones and Breast Cancer Collaborative Group","year":"2015","unstructured":"Endogenous Hormones and Breast Cancer Collaborative Group (2015) Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: reanalysis of eighteen prospective studies. Steroids 99:49\u201355","journal-title":"Steroids"},{"key":"3901_CR47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ijc.20582","volume":"113","author":"F Berrino","year":"2005","unstructured":"Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, Berselli E, Muti P, Secreto G (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499\u2013502","journal-title":"Int J Cancer"},{"key":"3901_CR48","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.2006.09.0118","volume":"25","author":"A Micheli","year":"2007","unstructured":"Micheli A, Meneghini E, Secreto G, Berrino F, Venturelli E, Cavalleri A, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Veronesi U, Formelli F (2007) Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol 25:2685\u20132690","journal-title":"J Clin Oncol"},{"key":"3901_CR49","first-page":"25","volume":"10","author":"F Berrino","year":"2001","unstructured":"Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G, Kaaks R (2001) Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomark Prev 10:25\u201333","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3901_CR50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1373\/clinchem.2005.052167","volume":"52","author":"MM Kushnir","year":"2006","unstructured":"Kushnir MM, Rockwood AL, Roberts WL, Pattison EG, Bunker AM, Fitzgerald RL, Meikle AW (2006) Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin Chem 52:120\u2013128","journal-title":"Clin Chem"},{"key":"3901_CR51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405\u2013413","journal-title":"J Clin Endocrinol Metab"},{"key":"3901_CR52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2007.07.013","volume":"386","author":"V Moal","year":"2007","unstructured":"Moal V, Mathieu E, Reynier P, Malthi\u00e8ry Y, Gallois Y (2007) Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques. Clin Chim Acta 386:12\u201319","journal-title":"Clin Chim Acta"},{"key":"3901_CR53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MED.0000000000000068","volume":"21","author":"H Ketha","year":"2014","unstructured":"Ketha H, Kaur S, Grebe SK, Singh RJ (2014) Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century. Curr Opin Endocrinol Diabetes Obes 21:217\u2013226","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3901_CR54","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.1986.260","volume":"54","author":"PN Plowman","year":"1986","unstructured":"Plowman PN, Nicholson RI, Walker KJ (1986) Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630. Br J Cancer 54:903\u2013909","journal-title":"Br J Cancer"},{"key":"3901_CR55","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/bjc.1989.331","volume":"60","author":"IL Crighton","year":"1989","unstructured":"Crighton IL, Dowsett M, Lal A, Man A, Smith IE (1989) Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects. Br J Cancer 60:644\u2013648","journal-title":"Br J Cancer"},{"key":"3901_CR56","first-page":"97","volume":"14","author":"M Dowsett","year":"1992","unstructured":"Dowsett M, Jacobs S, Aherne J, Smith IE (1992) Clinical and endocrine effects of leuprorelin acetate in pre- and postmenopausal patients with advanced breast cancer. Clin Ther 14:97\u2013103","journal-title":"Clin Ther"},{"key":"3901_CR57","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1200\/JCO.2002.05.042","volume":"20","author":"W Jonat","year":"2002","unstructured":"Jonat W, Kaufmann M, Sauerbrei W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes JC, de Matteis A, Stewart A, Eiermann W, Szakolczai I, Palmer M, Schumacher M, Geberth M, Lisboa B (2002) Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: Zoladex Early Breast Cancer Research Association Study. J Clin Oncol 20:4628\u20134635","journal-title":"J Clin Oncol"},{"key":"3901_CR58","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/jnci\/djg119","volume":"95","author":"M Castiglione-Gertsch","year":"2003","unstructured":"International Breast Cancer Study Group (IBCSG), Castiglione-Gertsch M, O\u2019Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M, Gelber RD (2003) Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 95:1833\u20131846","journal-title":"J Natl Cancer Inst"},{"key":"3901_CR59","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2006.08.8534","volume":"25","author":"P Schmid","year":"2007","unstructured":"Schmid P, Untch M, Koss\u00e9 V, Bondar G, Vassiljev L, Tarutinov V, Lehmann U, Maubach L, Meurer J, Wallwiener D, Possinger K (2007) Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study. J Clin Oncol 25:2509\u20132515","journal-title":"J Clin Oncol"},{"key":"3901_CR60","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMoa1404037","volume":"371","author":"O Pagani","year":"2014","unstructured":"Exemestane with ovarian suppression in premenopausal breast cancer, Pagani O, Regan MM, Francis PA (2014) Exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med 371:1358\u20131359","journal-title":"N Engl J Med"},{"key":"3901_CR61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0090-8258(91)90083-H","volume":"40","author":"CL Hughes Jr","year":"1991","unstructured":"Hughes CL Jr, Wall LL, Creasman WT (1991) Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol Oncol 40:42\u201345","journal-title":"Gynecol Oncol"},{"key":"3901_CR62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2265.1982.tb03179.x","volume":"16","author":"EJ Folkerd","year":"1982","unstructured":"Folkerd EJ, Jacobs HS, van der Spuy Z, James VH (1982) Failure of FSH to influence aromatization in human adipose tissue. Clin Endocrinol (Oxf) 16:621\u2013625","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3901_CR63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0022-4731(83)90239-X","volume":"19","author":"ER Simpson","year":"1983","unstructured":"Simpson ER, Cleland WH, Mendelson CR (1983) Aromatization of androgens by human adipose tissue in vitro. J Steroid Biochem 19:707\u2013713","journal-title":"J Steroid Biochem"},{"key":"3901_CR64","doi-asserted-by":"crossref","first-page":"16449","DOI":"10.1074\/jbc.270.27.16449","volume":"270","author":"Y Zhao","year":"1995","unstructured":"Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simpson ER (1995) Aromatase P450 gene expression in human adipose tissue. Role of a Jak\/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem 270:16449\u201316457","journal-title":"J Biol Chem"},{"key":"3901_CR65","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.57.3.6","volume":"57","author":"SE Bulun","year":"2005","unstructured":"Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B, Tamura M, Langoi D, Deb S (2005) Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 57:359\u2013383","journal-title":"Pharmacol Rev"},{"key":"3901_CR66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/jnci\/86.6.431","volume":"86","author":"DV Spicer","year":"1994","unstructured":"Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC (1994) Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 86:431\u2013436","journal-title":"J Natl Cancer Inst"},{"key":"3901_CR67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1507\/endocrj.K07E-053","volume":"55","author":"T Suzuki","year":"2008","unstructured":"Suzuki T, Miki Y, Akahira J, Moriya T, Ohuchi N, Sasano H (2008) Aromatase in human breast carcinomas a key regulator of intratumor sex steroid concentrations. Endocr J 55:455\u2013463","journal-title":"Endocr J"},{"key":"3901_CR68","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1158\/0008-5472.CAN-09-0452","volume":"69","author":"AA Peters","year":"2009","unstructured":"Peters AA, Buchanan G, Ricciarelli C, Bianco-Miotto T, Centenera MM, Harris JM, Jindal S, Segara D, Jia L, Moore NL, Henshall SM, Birrell SN, Coetzee GA, Sutherland RL, Butler LM, Tilley WD (2009) Androgen receptor inhibits estrogen receptor-a activity and is prognostic in breast cancer. Cancer Res 69:6131\u20136140","journal-title":"Cancer Res"},{"key":"3901_CR69","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1210\/me.2012-1107","volume":"26","author":"TE Hickey","year":"2012","unstructured":"Hickey\u00a0TE, Robinson JL, Carroll JS, Tilley WD (2012) Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 26:1252\u20131267","journal-title":"Mol Endocrinol"},{"key":"3901_CR70","doi-asserted-by":"crossref","first-page":"T161","DOI":"10.1530\/ERC-14-0243","volume":"21","author":"KM McNamara","year":"2014","unstructured":"McNamara KM, Moore NL, Hickey TE, Sasano H, Tilley WD (2014) Complexities of androgen receptor signalling in breast cancer. Endocr Relat Cancer 21:T161\u2013T181","journal-title":"Endocr Relat Cancer"},{"key":"3901_CR71","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1158\/0008-5472.CAN-07-2707","volume":"68","author":"S Massarweh","year":"2008","unstructured":"Massarweh S, Osborne CK, Creighton CJ, Qin L, Tsimelzon A, Huang S, Weiss H, Rimawi M, Schiff R (2008) Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res 68:826\u2013833","journal-title":"Cancer Res"},{"key":"3901_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-009-0436-8","volume":"121","author":"F Amicis De","year":"2010","unstructured":"De Amicis F, Thirugnansampanthan J, Cui Y, Selever J, Beyer A, Parra I, Weigel NL, Herynk MH, Tsimelzon A, Lewis MT, Chamness GC, Hilsenbeck SG, And\u00f2 S, Fuqua SA (2010) Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat 121:1\u201311","journal-title":"Breast Cancer Res Treat"},{"key":"3901_CR73","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10549-014-3082-8","volume":"147","author":"Y Rechoum","year":"2014","unstructured":"Rechoum Y, Rovito D, Iacopetta D, Barone I, And\u00f2 S, Weigel NL, O\u2019Malley BW, Brown PH, Fuqua SA (2014) AR collaborates with ER\u03b1 in aromatase inhibitor-resistant breast cancer. Breast Cancer Res Treat 147:473\u2013485","journal-title":"Breast Cancer Res Treat"},{"key":"3901_CR74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jsbmb.2014.08.019","volume":"144","author":"R Fujii","year":"2014","unstructured":"Fujii R, Hanamura T, Suzuki T, Gohno T, Shibahara Y, Niwa T, Yamaguchi Y, Ohnuki K, Kakugawa Y, Hirakawa H, Ishida T, Sasano H, Ohuchi N, Hayashi S (2014) Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma. J Steroid Biochem Mol Biol 144:513\u2013522","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3901_CR75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10549-015-3609-7","volume":"154","author":"A Ciupek","year":"2015","unstructured":"Ciupek A, Rechoum Y, Gu G, Gelsomino L, Beyer AR, Brusco L, Covington KR, Tsimelzon A, Fuqua SA (2015) Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ER\u03b1-positive breast cancer. Breast Cancer Res Treat 154:225\u2013237","journal-title":"Breast Cancer Res Treat"},{"key":"3901_CR76","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jncimonographs\/lgq035","volume":"41","author":"DC Allred","year":"2010","unstructured":"Allred DC (2010) Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr 41:134\u2013138","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"3901_CR77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1677\/erc.0.0080047","volume":"8","author":"DC Allred","year":"2001","unstructured":"Allred DC, Mohsin SK, Fuqua SA (2001) Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8(1):47\u201361","journal-title":"Endocr Relat Cancer"},{"key":"3901_CR78","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncr.11532","volume":"98","author":"F Moinfar","year":"2003","unstructured":"Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, Ratschek M, Tavassoli FA, Denk H (2003) Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 98:703\u2013711","journal-title":"Cancer"},{"key":"3901_CR79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/ERC-07-0092","volume":"15","author":"R Shibuya","year":"2008","unstructured":"Shibuya R, Suzuki T, Miki Y, Yoshida K, Moriya T, Ono K, Akahira J, Ishida T, Hirakawa H, Evans DB, Sasano H (2008) Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast. Endocr Relat Cancer 15:113\u2013124","journal-title":"Endocr Relat Cancer"},{"key":"3901_CR80","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/j.1349-7006.2010.01673.x","volume":"101","author":"Y Sasaki","year":"2010","unstructured":"Sasaki Y, Miki Y, Hirakawa H, Onodera Y, Takagi K, Akahira J, Honma S, Ishida T, Watanabe M, Sasano H, Suzuki T (2010) Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma. Cancer Sci 101:2286\u20132292","journal-title":"Cancer Sci"},{"key":"3901_CR81","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7150\/jca.2.232","volume":"2","author":"SA Lari","year":"2011","unstructured":"Lari SA, Kuerer HM (2011) Biological markers in DCIS and risk of breast recurrence: a systematic review. J Cancer 2:232\u2013261","journal-title":"J Cancer"},{"key":"3901_CR82","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.humpath.2007.07.007","volume":"39","author":"K Hanley","year":"2008","unstructured":"Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P (2008) Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Hum Pathol 39:386\u2013392","journal-title":"Hum Pathol"},{"key":"3901_CR83","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/annonc\/mdq586","volume":"22","author":"Q Yu","year":"2011","unstructured":"Yu Q, Niu Y, Liu N, Zhang JZ, Liu TJ, Zhang RJ, Wang SL, Ding SM, Xiao XQ (2011) Expression of androgen receptor in breast cancer and its significance as a prognostic factor. Ann Oncol 22:1288\u20131294","journal-title":"Ann Oncol"},{"issue":"16","key":"3901_CR84","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13058-014-0406-x","volume":"8","author":"BD Lehmann","year":"2014","unstructured":"Lehmann BD, Bauer JA, Schafer JM, Pendleton CS, Tang L, Johnson KC, Chen X, Balko JM, G\u00f3mez H, Arteaga CL, Mills GB, Sanders ME, Pietenpol JA (2014) PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors. Breast Cancer Res 8(16):406","journal-title":"Breast Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3901-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3901-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3901-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T22:10:28Z","timestamp":1656799828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3901-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,9]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3901"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3901-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,9]]}}}